Concepts (201)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Nitric Oxide Synthase Type III | 5 | 2019 | 87 | 2.72 | Why? |
| Vasodilation | 7 | 2019 | 258 | 2.30 | Why? |
| Blood Pressure | 3 | 2019 | 2198 | 0.92 | Why? |
| Phosphoproteins | 5 | 2020 | 4346 | 0.91 | Why? |
| Platelet Aggregation | 3 | 2018 | 318 | 0.91 | Why? |
| rac1 GTP-Binding Protein | 2 | 2018 | 32 | 0.90 | Why? |
| Mesenteric Arteries | 2 | 2017 | 22 | 0.87 | Why? |
| Endothelium, Vascular | 4 | 2019 | 1751 | 0.81 | Why? |
| Spirulina | 1 | 2019 | 18 | 0.78 | Why? |
| Intercellular Signaling Peptides and Proteins | 6 | 2021 | 245 | 0.74 | Why? |
| Protein Kinase C-alpha | 1 | 2017 | 12 | 0.70 | Why? |
| Longevity | 4 | 2021 | 159 | 0.70 | Why? |
| Nitric Oxide | 4 | 2019 | 769 | 0.65 | Why? |
| Phosphatidylinositol 3-Kinases | 1 | 2019 | 347 | 0.64 | Why? |
| Morus | 1 | 2016 | 41 | 0.63 | Why? |
| Calcium Signaling | 1 | 2017 | 133 | 0.63 | Why? |
| Proto-Oncogene Proteins c-akt | 1 | 2019 | 372 | 0.62 | Why? |
| Diabetes Mellitus, Experimental | 1 | 2018 | 192 | 0.61 | Why? |
| Plaque, Atherosclerotic | 1 | 2020 | 423 | 0.60 | Why? |
| Blood Platelets | 3 | 2018 | 1704 | 0.47 | Why? |
| Atherosclerosis | 1 | 2020 | 768 | 0.47 | Why? |
| Vascular Diseases | 2 | 2018 | 846 | 0.42 | Why? |
| Phosphorylation | 4 | 2018 | 1060 | 0.41 | Why? |
| Mice, Knockout | 5 | 2020 | 1815 | 0.41 | Why? |
| Bacterial Proteins | 1 | 2019 | 1318 | 0.40 | Why? |
| Endothelial Cells | 2 | 2018 | 2048 | 0.40 | Why? |
| Cerebrovascular Disorders | 1 | 2018 | 1040 | 0.39 | Why? |
| Receptors, CXCR4 | 2 | 2020 | 83 | 0.37 | Why? |
| Aminoquinolines | 2 | 2018 | 63 | 0.34 | Why? |
| Non-alcoholic Fatty Liver Disease | 1 | 2017 | 907 | 0.34 | Why? |
| Genetic Predisposition to Disease | 3 | 2020 | 4027 | 0.32 | Why? |
| Peptides | 1 | 2019 | 2513 | 0.32 | Why? |
| Blood Vessels | 2 | 2018 | 228 | 0.30 | Why? |
| Plant Extracts | 1 | 2016 | 1514 | 0.28 | Why? |
| Signal Transduction | 4 | 2018 | 7207 | 0.28 | Why? |
| Aging | 2 | 2018 | 3581 | 0.27 | Why? |
| Genetic Variation | 1 | 2017 | 3919 | 0.25 | Why? |
| Mice | 8 | 2020 | 21357 | 0.25 | Why? |
| Liver | 1 | 2017 | 4007 | 0.24 | Why? |
| Cardiovascular Diseases | 4 | 2021 | 11497 | 0.23 | Why? |
| Mice, Knockout, ApoE | 1 | 2020 | 42 | 0.22 | Why? |
| Animals | 13 | 2020 | 78931 | 0.22 | Why? |
| Mice, Inbred C57BL | 4 | 2020 | 5542 | 0.20 | Why? |
| Pyrimidines | 2 | 2018 | 1557 | 0.19 | Why? |
| Carotid Intima-Media Thickness | 1 | 2020 | 179 | 0.19 | Why? |
| Apolipoproteins E | 1 | 2020 | 170 | 0.19 | Why? |
| Trehalose | 1 | 2018 | 23 | 0.19 | Why? |
| Spermidine | 1 | 2018 | 56 | 0.19 | Why? |
| A Kinase Anchor Proteins | 1 | 2018 | 14 | 0.19 | Why? |
| Hypertension | 3 | 2021 | 8895 | 0.18 | Why? |
| Membrane Potentials | 1 | 2017 | 56 | 0.18 | Why? |
| Haplotypes | 2 | 2020 | 853 | 0.17 | Why? |
| Venous Insufficiency | 1 | 2017 | 22 | 0.17 | Why? |
| Cyclic AMP | 1 | 2017 | 76 | 0.17 | Why? |
| B7-H1 Antigen | 1 | 2021 | 541 | 0.17 | Why? |
| Atrial Natriuretic Factor | 1 | 2017 | 75 | 0.17 | Why? |
| Dose-Response Relationship, Drug | 2 | 2017 | 3776 | 0.17 | Why? |
| Diabetes Mellitus | 2 | 2021 | 8207 | 0.17 | Why? |
| NADPH Oxidase 2 | 1 | 2017 | 58 | 0.17 | Why? |
| Rats, Inbred SHR | 1 | 2016 | 58 | 0.16 | Why? |
| Saphenous Vein | 1 | 2017 | 67 | 0.16 | Why? |
| Gene Frequency | 2 | 2020 | 1210 | 0.16 | Why? |
| Protein Isoforms | 1 | 2017 | 347 | 0.15 | Why? |
| Multimodal Imaging | 1 | 2020 | 534 | 0.15 | Why? |
| HSP90 Heat-Shock Proteins | 1 | 2016 | 98 | 0.15 | Why? |
| Enzyme Activation | 1 | 2017 | 425 | 0.15 | Why? |
| eIF-2 Kinase | 1 | 2016 | 117 | 0.15 | Why? |
| Protein Transport | 1 | 2017 | 487 | 0.15 | Why? |
| Polyphenols | 1 | 2018 | 283 | 0.14 | Why? |
| Reactive Oxygen Species | 2 | 2018 | 1136 | 0.14 | Why? |
| HLA Antigens | 1 | 2020 | 830 | 0.14 | Why? |
| Endothelium | 1 | 2018 | 460 | 0.14 | Why? |
| Transfection | 1 | 2017 | 864 | 0.13 | Why? |
| Genetic Association Studies | 1 | 2017 | 559 | 0.13 | Why? |
| Oxidative Stress | 3 | 2018 | 2050 | 0.13 | Why? |
| Neovascularization, Pathologic | 1 | 2018 | 305 | 0.13 | Why? |
| Vasodilator Agents | 1 | 2017 | 344 | 0.13 | Why? |
| Aorta | 1 | 2017 | 355 | 0.13 | Why? |
| Ventricular Dysfunction, Right | 1 | 2021 | 639 | 0.13 | Why? |
| Platelet Activation | 1 | 2018 | 660 | 0.13 | Why? |
| Up-Regulation | 2 | 2021 | 2249 | 0.13 | Why? |
| Fatty Liver | 1 | 2017 | 299 | 0.12 | Why? |
| Ventricular Dysfunction, Left | 1 | 2021 | 993 | 0.12 | Why? |
| Chromatography, High Pressure Liquid | 1 | 2016 | 669 | 0.12 | Why? |
| Cells, Cultured | 3 | 2019 | 5835 | 0.12 | Why? |
| Mutation, Missense | 1 | 2017 | 863 | 0.11 | Why? |
| Alleles | 1 | 2017 | 1557 | 0.11 | Why? |
| Insulin Resistance | 1 | 2017 | 669 | 0.11 | Why? |
| Autophagy | 1 | 2018 | 960 | 0.11 | Why? |
| Recombinant Proteins | 2 | 2021 | 3786 | 0.11 | Why? |
| Mitochondria | 1 | 2018 | 857 | 0.11 | Why? |
| Cardiovascular System | 1 | 2018 | 750 | 0.10 | Why? |
| Administration, Oral | 1 | 2016 | 2340 | 0.09 | Why? |
| Heart | 1 | 2018 | 1791 | 0.09 | Why? |
| Biopsy | 1 | 2017 | 2811 | 0.09 | Why? |
| Adaptive Immunity | 1 | 2019 | 2585 | 0.09 | Why? |
| Protein Kinase Inhibitors | 1 | 2017 | 1585 | 0.08 | Why? |
| Monocytes | 1 | 2019 | 2978 | 0.08 | Why? |
| Cerebellar Cortex | 1 | 2006 | 5 | 0.08 | Why? |
| Hospital Mortality | 2 | 2021 | 22087 | 0.08 | Why? |
| Acute Coronary Syndrome | 1 | 2020 | 2107 | 0.08 | Why? |
| Analysis of Variance | 2 | 2021 | 950 | 0.08 | Why? |
| Risk | 1 | 2018 | 5288 | 0.07 | Why? |
| Male | 16 | 2021 | 367725 | 0.07 | Why? |
| Disease Susceptibility | 1 | 2018 | 4002 | 0.07 | Why? |
| Female | 14 | 2021 | 380317 | 0.07 | Why? |
| Polymorphism, Single Nucleotide | 1 | 2017 | 3607 | 0.07 | Why? |
| Middle Aged | 9 | 2021 | 270681 | 0.07 | Why? |
| Humans | 20 | 2021 | 930598 | 0.07 | Why? |
| Blood Glucose | 1 | 2018 | 3642 | 0.07 | Why? |
| Hippocampus | 1 | 2006 | 237 | 0.06 | Why? |
| Cell Movement | 2 | 2018 | 695 | 0.06 | Why? |
| Cardiac Output, Low | 1 | 2002 | 31 | 0.06 | Why? |
| Integrin beta1 | 1 | 2002 | 20 | 0.06 | Why? |
| Muscle Proteins | 1 | 2002 | 64 | 0.06 | Why? |
| Cytoskeletal Proteins | 1 | 2002 | 63 | 0.06 | Why? |
| Cardiomegaly | 1 | 2002 | 96 | 0.06 | Why? |
| Models, Biological | 1 | 2018 | 4907 | 0.05 | Why? |
| Inflammation | 2 | 2021 | 13255 | 0.05 | Why? |
| Age Factors | 2 | 2021 | 21039 | 0.05 | Why? |
| Genetics, Population | 1 | 2020 | 162 | 0.05 | Why? |
| Cytotoxicity, Immunologic | 1 | 2021 | 287 | 0.05 | Why? |
| Publication Bias | 1 | 2021 | 241 | 0.05 | Why? |
| HLA-B Antigens | 1 | 2020 | 166 | 0.05 | Why? |
| Aged | 7 | 2021 | 215776 | 0.05 | Why? |
| Carrier Proteins | 1 | 2002 | 513 | 0.05 | Why? |
| Leukocytes, Mononuclear | 2 | 2021 | 2115 | 0.05 | Why? |
| HLA-DRB1 Chains | 1 | 2020 | 196 | 0.05 | Why? |
| HLA-C Antigens | 1 | 2020 | 195 | 0.05 | Why? |
| HLA-A Antigens | 1 | 2020 | 196 | 0.05 | Why? |
| Italy | 5 | 2021 | 38444 | 0.05 | Why? |
| Biomarkers | 2 | 2021 | 23361 | 0.04 | Why? |
| Case-Control Studies | 1 | 2017 | 17671 | 0.04 | Why? |
| Autophagy-Related Proteins | 1 | 2018 | 157 | 0.04 | Why? |
| Cardiac Imaging Techniques | 1 | 2020 | 357 | 0.04 | Why? |
| NADP | 1 | 2017 | 41 | 0.04 | Why? |
| Glucose Transporter Type 1 | 1 | 2017 | 30 | 0.04 | Why? |
| Aged, 80 and over | 7 | 2021 | 88759 | 0.04 | Why? |
| Immunoblotting | 1 | 2017 | 180 | 0.04 | Why? |
| Aortic Coarctation | 2 | 2006 | 21 | 0.04 | Why? |
| Random Allocation | 1 | 2018 | 773 | 0.04 | Why? |
| Reference Values | 1 | 2018 | 795 | 0.04 | Why? |
| Statistics, Nonparametric | 1 | 2018 | 1008 | 0.03 | Why? |
| Adrenomedullin | 1 | 2017 | 217 | 0.03 | Why? |
| Interleukin-1beta | 1 | 2019 | 992 | 0.03 | Why? |
| Geography | 1 | 2020 | 1801 | 0.03 | Why? |
| Regression Analysis | 1 | 2021 | 2484 | 0.03 | Why? |
| Prognosis | 3 | 2021 | 32490 | 0.03 | Why? |
| Quarantine | 1 | 2020 | 18418 | 0.03 | Why? |
| Observational Studies as Topic | 1 | 2021 | 1887 | 0.03 | Why? |
| Vascular Endothelial Growth Factor A | 1 | 2017 | 604 | 0.03 | Why? |
| Prospective Studies | 1 | 2017 | 43301 | 0.03 | Why? |
| Stroke Volume | 1 | 2021 | 2153 | 0.03 | Why? |
| Risk Factors | 4 | 2021 | 71621 | 0.03 | Why? |
| Echocardiography | 2 | 2021 | 3661 | 0.03 | Why? |
| Coronary Angiography | 1 | 2020 | 2275 | 0.03 | Why? |
| Tumor Necrosis Factor-alpha | 1 | 2019 | 2483 | 0.02 | Why? |
| Epithelial Cells | 1 | 2021 | 3508 | 0.02 | Why? |
| Brain | 1 | 2006 | 5133 | 0.02 | Why? |
| Adult | 4 | 2021 | 244371 | 0.02 | Why? |
| Smoking | 1 | 2021 | 3358 | 0.02 | Why? |
| Time Factors | 2 | 2020 | 31397 | 0.02 | Why? |
| NADPH Oxidases | 1 | 2006 | 80 | 0.02 | Why? |
| Cell Line | 1 | 2021 | 12040 | 0.02 | Why? |
| Neuronal Plasticity | 1 | 2006 | 98 | 0.02 | Why? |
| Immunologic Factors | 1 | 2021 | 4206 | 0.02 | Why? |
| Disease Models, Animal | 2 | 2018 | 10998 | 0.02 | Why? |
| Phenylephrine | 1 | 2002 | 20 | 0.02 | Why? |
| Magnetic Resonance Imaging | 1 | 2020 | 6551 | 0.02 | Why? |
| Astrocytes | 1 | 2006 | 298 | 0.02 | Why? |
| Europe | 1 | 2020 | 12702 | 0.02 | Why? |
| Sex Factors | 1 | 2021 | 11014 | 0.02 | Why? |
| Cytokines | 2 | 2021 | 15010 | 0.02 | Why? |
| Health Status | 1 | 2017 | 3259 | 0.02 | Why? |
| Stress, Mechanical | 1 | 2002 | 143 | 0.02 | Why? |
| Atrial Fibrillation | 1 | 2017 | 2320 | 0.02 | Why? |
| Cerebrovascular Circulation | 1 | 2006 | 340 | 0.02 | Why? |
| Ventricular Function | 1 | 2002 | 93 | 0.01 | Why? |
| Chronic Disease | 1 | 2017 | 5139 | 0.01 | Why? |
| Biomechanical Phenomena | 1 | 2002 | 291 | 0.01 | Why? |
| Gene Silencing | 1 | 2002 | 213 | 0.01 | Why? |
| Blood-Brain Barrier | 1 | 2006 | 531 | 0.01 | Why? |
| Vasoconstrictor Agents | 1 | 2002 | 714 | 0.01 | Why? |
| Incidence | 1 | 2020 | 25622 | 0.01 | Why? |
| Risk Assessment | 1 | 2021 | 25439 | 0.01 | Why? |
| Angiotensin II | 1 | 2002 | 601 | 0.01 | Why? |
| Betacoronavirus | 1 | 2020 | 204454 | 0.01 | Why? |
| Muscle, Skeletal | 1 | 2002 | 915 | 0.01 | Why? |
| Hemodynamics | 1 | 2002 | 1562 | 0.01 | Why? |
| Heart Ventricles | 1 | 2002 | 1139 | 0.01 | Why? |
| Tomography, X-Ray Computed | 1 | 2020 | 25144 | 0.01 | Why? |
| Severity of Illness Index | 1 | 2021 | 48226 | 0.01 | Why? |
| Acute Disease | 1 | 2006 | 6029 | 0.01 | Why? |
| Lung | 1 | 2021 | 31049 | 0.01 | Why? |
| Pneumonia, Viral | 1 | 2020 | 243684 | 0.01 | Why? |
| Coronavirus Infections | 1 | 2020 | 253789 | 0.01 | Why? |
| Myocardium | 1 | 2002 | 2323 | 0.01 | Why? |
| Retrospective Studies | 1 | 2021 | 105322 | 0.01 | Why? |
| Adolescent | 1 | 2017 | 86841 | 0.00 | Why? |
| Young Adult | 1 | 2017 | 93724 | 0.00 | Why? |
| Pandemics | 2 | 2020 | 389249 | 0.00 | Why? |
Vecchione's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(201)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(131)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_